| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aldeyra Therapeutics Inc (NASDAQ: ALDX)
ALDX Technical Analysis
5
| As on 4th Apr 2025 ALDX SHARE Price closed @ 1.89 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.62 & Strong Sell for SHORT-TERM with Stoploss of 2.66 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALDXSHARE Price
| Open | 1.40 | Change | Price | % |
| High | 2.00 | 1 Day | 0.47 | 33.10 |
| Low | 1.38 | 1 Week | -4.41 | -70.00 |
| Close | 1.89 | 1 Month | -4.80 | -71.75 |
| Volume | 12994312 | 1 Year | 0.06 | 3.28 |
| 52 Week High 6.98 | 52 Week Low 1.47 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 94.31 | -7.36% |
| TSLA | 239.43 | -10.42% |
| INTC | 19.85 | -11.50% |
| AAPL | 188.38 | -7.29% |
| AMZN | 171.00 | -4.15% |
| RSLS | 0.46 | 21.05% |
| LMDX | 0.02 | 0.00% |
| AAL | 9.46 | -0.53% |
| LCID | 2.28 | -1.72% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALDX Daily Charts |
ALDX Intraday Charts |
Whats New @ Bazaartrend |
ALDX Free Analysis |
|
|
ALDX Important Levels Intraday
| RESISTANCE | 3.08 |
| RESISTANCE | 2.70 |
| RESISTANCE | 2.46 |
| RESISTANCE | 2.23 |
| SUPPORT | 1.55 |
| SUPPORT | 1.32 |
| SUPPORT | 1.08 |
| SUPPORT | 0.70 |
ALDX Forecast April 2025
| 4th UP Forecast | 4.78 |
| 3rd UP Forecast | 3.85 |
| 2nd UP Forecast | 3.28 |
| 1st UP Forecast | 2.71 |
| 1st DOWN Forecast | 1.07 |
| 2nd DOWN Forecast | 0.5 |
| 3rd DOWN Forecast | -0.07 |
| 4th DOWN Forecast | -1 |
ALDX Weekly Forecast
| 4th UP Forecast | 2.49 |
| 3rd UP Forecast | 2.30 |
| 2nd UP Forecast | 2.18 |
| 1st UP Forecast | 2.06 |
| 1st DOWN Forecast | 1.72 |
| 2nd DOWN Forecast | 1.60 |
| 3rd DOWN Forecast | 1.48 |
| 4th DOWN Forecast | 1.29 |
ALDX Forecast2025
| 4th UP Forecast | 13.57 |
| 3rd UP Forecast | 9.82 |
| 2nd UP Forecast | 7.51 |
| 1st UP Forecast | 5.19 |
| 1st DOWN Forecast | -1.41 |
| 2nd DOWN Forecast | -3.73 |
| 3rd DOWN Forecast | -6.04 |
| 4th DOWN Forecast | -9.79 |
Aldeyra Therapeutics Inc ( NASDAQ USA Symbol : ALDX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALDX Business Profile
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of primary vitreoretinal lymphoma. The company's portfolio also consists of ADX-1612, a small molecule heat shock protein 90 (Hsp90) inhibitor for the treatment of lymphoproliferative diseases and covid-19; and reactive aldehyde species that are pro-inflammatory (RASP) scavengers, such as ADX-629 for treating autoimmune diseases, allergy, and covid-19, as well as ADX-103 for the treatment of retinal diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is headquartered in Lexington, Massachusetts. Address: 131 Hartwell Avenue, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service